T81.4 N17.8 F05.9
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: As this is a retrospective, single-center cohort study, there is no prospective recruitment and no formal a priori sample size calculation of the type used in interventional studies. The analysis includes all consecutive patients who underwent surgery at the participating clinics during the study period from January 1, 2019, to April 15, 2026, who meet the inclusion and exclusion criteria, and for whom an evaluable preoperative medication history and documentation of the endpoints are available.
Exclusion criteria
Exclusion criteria: Missing data regarding patients' prior medication, documentation of postoperative complications, or preoperative and postoperative blood values ??(see primary and secondary endpoints).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| primary endpoint: occurrence of postoperative complications o Acute kidney injury o Postoperative delirium o Cardiac arrhythmias o Sepsis Assessment during the first four postoperative days. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints: Modulation of inflammation o Leukocyte count pre- and postoperatively (measured in blood) o Blood glucose level pre- and postoperatively (measured in blood) Time of measurement: during routine preoperative laboratory testing and the first routine postoperative laboratory testing | — |
Countries
Germany
Contacts
Uniklinikum RWTH Aachen